ELIC — Elicera Therapeutics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Elicera Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	11.6	52.4	43.8	29.4	26.4
Net Total Receivables	0.446	0.204	1.98	0.784	1.17
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12.1	54.2	45.8	30.2	27.6
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12.6	54.7	46.3	30.2	27.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.35	2.5	13.5	13.8	6.8
Total Long Term Debt
Total Debt
Total Liabilities	2.35	2.5	13.5	13.8	6.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10.2	52.2	32.8	16.4	20.8
Total Liabilities & Shareholders' Equity	12.6	54.7	46.3	30.2	27.6
Total Common Shares Outstanding